Cargando…
ATR promotes mTORC1 activation via de novo cholesterol synthesis in p16-low cancer cells
DNA damage and cellular metabolism are intricately linked with bidirectional feedback. Two of the main effectors of the DNA damage response and control of cellular metabolism are ATR and mTORC1, respectively. Prior work has placed ATR upstream of mTORC1 during replication stress, yet the direct mech...
Autores principales: | Tangudu, Naveen Kumar, Huang, Zhentai, Fang, Richard, Buj, Raquel, Uboveja, Apoorva, Cole, Aidan R., Happe, Cassandra, Sun, Mai, Gelhaus, Stacy L., MacDonald, Matthew L., Hempel, Nadine, Snyder, Nathaniel W., Aird, Katherine M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634888/ https://www.ncbi.nlm.nih.gov/pubmed/37961201 http://dx.doi.org/10.1101/2023.10.27.564195 |
Ejemplares similares
-
De novo purine metabolism is a metabolic vulnerability of cancers with low p16 expression
por: Tangudu, Naveen Kumar, et al.
Publicado: (2023) -
ATM inhibition drives metabolic adaptation via induction of macropinocytosis
por: Huang, Zhentai, et al.
Publicado: (2022) -
Loss of p16: A Bouncer of the Immunological Surveillance?
por: Leon, Kelly E., et al.
Publicado: (2021) -
Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic Reprogramming
por: Buj, Raquel, et al.
Publicado: (2019) -
mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016)